• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer.CD147 与氨基酸转运体(LAT1 和 ASCT2)在胰腺癌患者中的表达关系。
Am J Transl Res. 2015 Feb 15;7(2):356-63. eCollection 2015.
2
Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.手术切除的舌癌中氨基酸转运蛋白表达(LAT1、ASCT2 和 xCT)的预后意义。
Br J Cancer. 2014 May 13;110(10):2506-13. doi: 10.1038/bjc.2014.178. Epub 2014 Apr 24.
3
Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.氨基酸转运体(LAT1、ASCT2和xCT)在肝细胞癌中的表达及其临床意义
Hepatol Res. 2015 Sep;45(9):1014-1022. doi: 10.1111/hepr.12431. Epub 2014 Dec 11.
4
Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.III/IV期喉鳞状细胞癌患者中氨基酸转运体(LAT1和ASCT2)的表达
Pathol Oncol Res. 2015 Sep;21(4):1175-81. doi: 10.1007/s12253-015-9954-3. Epub 2015 May 30.
5
Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma.L型氨基酸转运体1(LAT1)与ASC氨基酸转运体2(ASCT2)共表达在肺腺癌中的临床意义
Am J Transl Res. 2015 Jun 15;7(6):1126-39. eCollection 2015.
6
Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors.L型氨基酸转运体1(LAT1)表达在卵巢肿瘤患者中的预后意义。
Am J Transl Res. 2015 Jun 15;7(6):1161-71. eCollection 2015.
7
Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma.LAT1和ASCT2在手术切除的食管鳞状细胞癌患者中的临床病理意义
J Surg Oncol. 2016 Mar;113(4):381-9. doi: 10.1002/jso.24160. Epub 2016 Mar 3.
8
Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma.ASC氨基酸转运体-2在胰腺导管癌中的临床病理意义
Histopathology. 2015 Jan;66(2):234-43. doi: 10.1111/his.12464. Epub 2014 Dec 23.
9
Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.靶向抑制和敲除上皮和间充质人肝癌细胞中的 ASCT2 或 LAT1 并不能抑制其生长。
Int J Mol Sci. 2018 Jul 19;19(7):2093. doi: 10.3390/ijms19072093.
10
Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.肺多形性癌中氨基酸转运体(LAT1 和 4F2hc)的表达。
Hum Pathol. 2019 Feb;84:142-149. doi: 10.1016/j.humpath.2018.09.020. Epub 2018 Oct 6.

引用本文的文献

1
SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer.溶质载体家族1成员5(SLC1A5)是谷氨酰胺代谢的关键调节因子,也是侵袭性管腔型乳腺癌的预后标志物。
Sci Rep. 2025 Jan 22;15(1):2805. doi: 10.1038/s41598-025-87292-1.
2
A Review on the Role of Human Solute Carriers Transporters in Cancer.人类溶质载体转运蛋白在癌症中的作用综述
Health Sci Rep. 2025 Jan 12;8(1):e70343. doi: 10.1002/hsr2.70343. eCollection 2025 Jan.
3
Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers.将溶质载体转运蛋白(SLCs)作为不同癌症的治疗靶点
Diseases. 2024 Mar 21;12(3):63. doi: 10.3390/diseases12030063.
4
CD147: an integral and potential molecule to abrogate hallmarks of cancer.CD147:一种消除癌症特征的不可或缺的潜在分子。
Front Oncol. 2023 Nov 7;13:1238051. doi: 10.3389/fonc.2023.1238051. eCollection 2023.
5
CD147 Facilitates the Pathogenesis of Psoriasis through Glycolysis and H3K9me3 Modification in Keratinocytes.CD147通过角质形成细胞中的糖酵解和H3K9me3修饰促进银屑病的发病机制。
Research (Wash D C). 2023 Jun 8;6:0167. doi: 10.34133/research.0167. eCollection 2023.
6
Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways.LAT1-4F2hc通过Toll样受体及其他重要途径在泌尿系统癌症中的作用
Cancers (Basel). 2022 Jan 4;14(1):229. doi: 10.3390/cancers14010229.
7
Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.LAT3 在前列腺癌中的功能分析:其下游靶标与雄激素受体的关系。
Cancer Sci. 2021 Sep;112(9):3871-3883. doi: 10.1111/cas.14991. Epub 2021 Jul 8.
8
Emerging roles of the solute carrier family in pancreatic cancer.溶质载体家族在胰腺癌中的新作用。
Clin Transl Med. 2021 Mar;11(3):e356. doi: 10.1002/ctm2.356.
9
ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation.ASCT2和LAT1对癌症特征的作用:从分子角度到临床转化
Cancers (Basel). 2021 Jan 8;13(2):203. doi: 10.3390/cancers13020203.
10
The Harmonious Interplay of Amino Acid and Monocarboxylate Transporters Induces the Robustness of Cancer Cells.氨基酸和单羧酸转运体的和谐相互作用诱导癌细胞的强健性。
Metabolites. 2021 Jan 2;11(1):27. doi: 10.3390/metabo11010027.

本文引用的文献

1
CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway.CD147-CD98hc复合物通过PI3K/Akt信号通路促进细胞增殖,从而导致非小细胞肺癌患者预后不良。
Ann Surg Oncol. 2014 Dec;21(13):4359-68. doi: 10.1245/s10434-014-3816-1. Epub 2014 Aug 2.
2
Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma.ASC氨基酸转运体-2在胰腺导管癌中的临床病理意义
Histopathology. 2015 Jan;66(2):234-43. doi: 10.1111/his.12464. Epub 2014 Dec 23.
3
ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.天冬氨酸-丝氨酸-胱氨酸转运蛋白 2(ASCT2)作为非小细胞肺癌的新型预后标志物。
Br J Cancer. 2014 Apr 15;110(8):2030-9. doi: 10.1038/bjc.2014.88. Epub 2014 Mar 6.
4
Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer.L 型氨基酸转运蛋白 1 表达在胰腺癌手术切除中的预后意义。
Br J Cancer. 2012 Aug 7;107(4):632-8. doi: 10.1038/bjc.2012.310. Epub 2012 Jul 17.
5
CD98 at the crossroads of adaptive immunity and cancer.CD98 在适应性免疫和癌症的十字路口。
J Cell Sci. 2012 Mar 15;125(Pt 6):1373-82. doi: 10.1242/jcs.096040. Epub 2012 Apr 12.
6
CD147 silencing via RNA interference reduces tumor cell invasion, metastasis and increases chemosensitivity in pancreatic cancer cells.RNA 干扰沉默 CD147 可降低胰腺癌细胞的侵袭、转移能力并增加化疗敏感性。
Oncol Rep. 2012 Jun;27(6):2003-9. doi: 10.3892/or.2012.1729. Epub 2012 Mar 15.
7
LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer.LAT1 表达与切除的非小细胞肺癌中的缺氧标志物和 mTOR 密切相关。
Am J Transl Res. 2011;3(5):468-78. Epub 2011 Oct 7.
8
Cancer-related issues of CD147.CD147 与癌症相关的问题。
Cancer Genomics Proteomics. 2010 May-Jun;7(3):157-69.
9
CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.CD98 的表达与淋巴结转移的可切除非小细胞肺癌的不良预后相关。
Ann Surg Oncol. 2009 Dec;16(12):3473-81. doi: 10.1245/s10434-009-0685-0. Epub 2009 Sep 24.
10
CD147 impacts angiogenesis and metastasis formation.CD147影响血管生成和转移灶形成。
Cancer Invest. 2009 Mar;27(3):329-33. doi: 10.1080/07357900802392675.

CD147 与氨基酸转运体(LAT1 和 ASCT2)在胰腺癌患者中的表达关系。

Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer.

机构信息

Department of Oncology Clinical Development, Gunma University Graduate School of Medicine Showa-machi, Maebashi, Gunma, Japan.

Department of Surgery, Maebashi Red Cross Hospital Asahi-cho, Maebashi, Gunma, Japan.

出版信息

Am J Transl Res. 2015 Feb 15;7(2):356-63. eCollection 2015.

PMID:25901202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4399098/
Abstract

CD147 functions as an induction of matrix metalloproteinases and tumor angiogenesis, and is highly expressed in various malignant neoplasms. Recently, CD147 is shown to form a complex with amino acid transporters such as L-type amino acid transporter (LAT1), system ASC amino acid transporter-2 (ASCT2) and 4F2hc as a heavy chain of LAT1. It remains unknown about the existence of these complexes in patients with pancreatic cancer. The aim of this study is to investigate the relationship between CD147 and these amino acid transporters. Ninety-seven patients with pancreatic cancer were evaluated. Tumor sections were stained by immunohistochemistry for LAT1, ASCT2, Ki-67, microvessel density (MVD) determined by CD34, p-AKT, and p-mTOR. CD147 was highly expressed in 23% (22/97) of patients. A high expression of CD147 is significantly associated with N factor, LAT1, ASCT2, Ki-67, VEGF and p-mTOR. A high CD147 expression was identified as a significant prognostic predictor by univariate survival analysis. The coexpression of CD147 and LAT1, and that of CD147 and 4F2hc yielded a significantly worse prognosis than the single expression of LAT1, and that of 4F2hc, respectively. CD147 revealed a significant relationship with the expression level of LAT1 and ASCT2, correlated with tumor proliferation, angiogenesis and mTOR signaling.

摘要

CD147 作为基质金属蛋白酶和肿瘤血管生成的诱导因子,在各种恶性肿瘤中高度表达。最近,CD147 被证明与氨基酸转运体如 L 型氨基酸转运体(LAT1)、系统 ASC 氨基酸转运体-2(ASCT2)和 4F2hc 形成复合物,作为 LAT1 的重链。这些复合物在胰腺癌患者中是否存在尚不清楚。本研究旨在探讨 CD147 与这些氨基酸转运体之间的关系。评估了 97 例胰腺癌患者。肿瘤切片通过免疫组织化学染色检测 LAT1、ASCT2、Ki-67、CD34 确定的微血管密度(MVD)、p-AKT 和 p-mTOR。23%(22/97)的患者 CD147 高表达。CD147 的高表达与 N 因子、LAT1、ASCT2、Ki-67、VEGF 和 p-mTOR 显著相关。单因素生存分析表明,CD147 高表达是一个显著的预后预测因子。CD147 与 LAT1 的共表达,以及与 4F2hc 的共表达,与 LAT1 和 4F2hc 的单表达相比,预后明显更差。CD147 与 LAT1 和 ASCT2 的表达水平显著相关,与肿瘤增殖、血管生成和 mTOR 信号相关。